Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer’s Disease Are Associated with the Peripheral Suppression of Inflammation
Cells · 2025
DOI: 10.3390/cells14151189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Joanna Dunacka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59 Street, 80-308 Gdansk, Poland. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Alzheimer Disease, Inflammation, Antidepressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was partly funded by Statutory Activities of the Department of Animal and Human Physiology of the University of Gdansk, Statutory Activities of the Department of Animal and Human Physiology of the University of Gdansk.
Themen: Demenz
Abstract (Originalsprache)
(1) Insulin-like growth factor-1 (IGF-1) is a neurotrophin with anti-inflammatory properties. Neuroinflammation and stress activate peripheral immune mechanisms, which may contribute to the development of depression and anxiety in sporadic Alzheimer’s disease (sAD). This study aims to evaluate whether intracerebroventricular (ICV) premedication with IGF-1 in a rat model of streptozotocin (STZ)-induced neuroinflammation can prevent the emergence of anhedonia and anxiety-like behavior by impacting the peripheral inflammatory responses. (2) Male Wistar rats were subjected to double ICVSTZ (total dose: 3 mg/kg) and ICVIGF-1 injections (total dose: 2 µg). We analyzed the level of anhedonia (sucrose preference), anxiety (elevated plus maze), peripheral inflammation (hematological and cytometric measurement of leukocyte populations, interleukin (IL)-6), and corticosterone concentration at 7 (very early stage, VES), 45 (early stage, ES), and 90 days after STZ injections (late stage, LS). (3) We found that ICVIGF-1 administration reduces behavioral symptoms: anhedonia (ES and LS) and anxiety (VES, ES), and peripheral inflammation: number of leukocytes, lymphocytes, T lymphocytes, monocytes, granulocytes, IL-6, and corticosterone concentration (LS) in the rat model of sAD. (4) The obtained results demonstrate beneficial effects of central IGF-1 administration on neuropsychiatric symptoms and peripheral immune system activation during disease progression in the rat model of sAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59 Street, 80-308 Gdansk, Poland.
ORCID-Profile: Joanna Dunacka, Beata Grembecka, Danuta Wrona
Förderung
- This research was partly funded by Statutory Activities of the Department of Animal and Human Physiology of the University of Gdansk
- Statutory Activities of the Department of Animal and Human Physiology of the University of Gdansk
Zitieren
APA
Dunacka, J., Grembecka, B., & Wrona, D. (2025). Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer’s Disease Are Associated with the Peripheral Suppression of Inflammation. Cells. https://doi.org/10.3390/cells14151189
Vancouver
Dunacka J, Grembecka B, Wrona D. Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer’s Disease Are Associated with the Peripheral Suppression of Inflammation. Cells. 2025. doi:10.3390/cells14151189
BibTeX
@article{Dunacka2025,
author = {Dunacka, Joanna and Grembecka, Beata and Wrona, Danuta},
title = {Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer’s Disease Are Associated with the Peripheral Suppression of Inflammation},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14151189}
}
EUVIMED